Healthcare Stocks
Abbott (ABT), Anthem (ANTM) stocks rise after upbeat revenue outlook
- October 20, 2021 09:23 AM PDT
- Ipsita Sarkar
Highlights Abbott Laboratories’ (NYSE: ABT) third-quarter sales rose 23.4% to US$10.9 billion YoY. Abbott raised its full-year adjusted EPS guidance to between US$5.00 and US$5.10. Anthem, Inc’s (NYSE: ANTM) operating revenue jump...
PROG, ADMP stocks jump after FDA approval, patent rights
- October 18, 2021 05:12 PM PDT
- Sanjeeb Baruah
Seven stocks to explore as demand for healthcare soars
- October 15, 2021 06:15 PM PDT
- Ipsita Sarkar
Why is the stock of gene-editing titan CRISPR hogging attention?
- October 14, 2021 05:37 PM PDT
- Sanjeeb Baruah
Walgreens Boots (WBA) profits up 6.4% in Q4 as sales surge
- October 14, 2021 03:19 PM PDT
- Sanjeeb Baruah
Walgreens Boots (WBA) profits up 6.4% in Q4 as sales surge
- October 14, 2021 03:19 PM PDT
- Sanjeeb Baruah
Pharmacy chain operator Walgreens Boots Alliance Reports on Thursday reported a fourth-quarter profit of US$358 million after witnessing robust growth in the US and the UK markets. Walgreens’ net earnings from operations increased by 6.4% Yo...
Read More...
UnitedHealth (UNH) raises guidance on strong Q3 growth, revenue up 11%
- October 14, 2021 07:31 AM PDT
- Ipsita Sarkar
Highlights UnitedHealth Group (NYSE: UNH) declared third-quarter results on Thursday. The group served 146 million people across its businesses as of September 30, 2021. UNH posted revenue of US$72.3 billion and 23.5% return on equity in the t...
Read More...
Nutriband (NTRB), Protara (TARA) stocks gallop on deals, drug approval
- October 12, 2021 02:00 PM PDT
- Ipsita Sarkar
Highlights Nutriband Inc. (NASDAQ: NTRB) stock jumped on securing a lucrative manufacturing deal with San Diego-based Diomics for its Diocheck™ technology. Protara Therapeutics, Inc. (NASDAQ: TARA) climbed 11.41% after receiving FDA clear...
Read More...
CLOV, ADMS stocks up on rating upgrade, purchase deal
- October 11, 2021 11:10 AM PDT
- Ipsita Sarkar
Highlights Stocks of Clover Health Investments, Corp. (NASDAQ: CLOV) and Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) were gaining traction on Monday. The Centers for Medicare and Medicaid Services (CMS) upgraded the CLOV stock to a 3.5-star rat...
Read More...
ChemoCentryx (CCXI), Vaxart (VXRT) stocks rally on upbeat drug news
- October 08, 2021 09:18 AM PDT
- Ipsita Sarkar
Highlights FDA has approved ChemoCentryx's drug Avacopan, to be sold under the brand name Tavneos. A Duke University study showed Vaxart's oral drug is more effective in reducing SARS-CoV-2 transmission. Vaxart, Inc. (NASDAQ: VXRT) stock...
Read More...
Voyager Therapeutics (VYGR) stock jumps 56% on Pfizer licensing deal
- October 06, 2021 03:29 PM PDT
- Sanjeeb Baruah
Highlights Voyager Therapeutics, Inc. (NASDAQ: VYGR) sealed a license option deal with Pfizer worth around US$630 million. Pfizer may exercise the option to use Voyager’s RNA-driven TRACERTM screening technology for developing its gene th...
Read More...
Ocugen (OCGN) & Aditxt (ADTX): Two trending biotech stocks
- October 05, 2021 12:34 PM PDT
- Team Kalkine Media
Highlights Ocugen, Inc. (NASDAQ: OCGN) has entered into a development and supply agreement with Bharat Biotech for a Covid-19 vaccine candidate. Aditxt, Inc. (NASDAQ: ADTX) has entered into a transaction agreement for acquiring a subsidiary of ...
Read More...
Xenon (XENE), OpGen (OPGN) stocks soar on drug results, FDA approval
- October 04, 2021 04:12 PM PDT
- Team Kalkine Media
Highlights Xenon Pharmaceuticals Inc. (NASDAQ: XENE) achieved positive topline results from phase-2b clinical trials of‘XEN1101’ for treating focal epilepsy. OpGen, Inc. (NASDAQ: OPGN) got 510(k) received FDA clearance to mark...
Read More...
ALZN & AEZS: Two trending biotechnology stocks on Friday
- October 01, 2021 10:56 AM PDT
- Ipsita Sarkar
Highlights Aeterna Zentaris Inc. (NASDAQ: AEZS) develops diagnostic and therapeutic tests. Alzamend Neuro, Inc. (NASDAQ: ALZN) develops treatment for neurodegenerative diseases and psychiatric disorders. Aeterna has been placed on NASDAQ...
Read More...
Atea (AVIR) & Catalyst (CPRX): Two trending healthcare stocks today
- September 30, 2021 01:48 PM PDT
- Team Kalkine Media
Highlights Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) stocks surged 11.24 percent to US$35.74 on September 30. Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) jumped 7.97 percent to US$5.42 at 1.50 pm on Thursday. CPRX received a favorable court ...
Read More...